Found 39 matching trials
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients PHASE1 The goal of this clinical trial is to evaluate the safety and effectiveness...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact NA In sepsis and septic shock, the host response is characterized by a complex...
Show More Location
intensive care unit of the University Hospital Center La Rabta
Learn More & Join Trial
Insulin Iontophoresis Mixed With Oleic Acid Versus Topical Insulin in Patients With Chronic Diabetic Foot Ulcer NA This study will be conducted to investigate the effect of Insulin iontophor...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis PHASE1 Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages NA Aneurysmal subarachnoid hemorrhage (aSAH) is a dreadful acute neurological ...
Show More Location
Hamad General Hospital
Learn More & Join Trial
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection PHASE2 A controlled clinical trial was conducted at eight participating centers be...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass PHASE2 This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Show More Learn More & Join Trial
Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ER NA Acute diarrhea and acute colitis of infectious origin are common reasons fo...
Show More Location
Pitié Salpetriere
Learn More & Join Trial
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma PHASE1 A phase I dose escalation study of veltuzumab and milatuzumab in relapsed a...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin PHASE1 This dose-escalating study consists of 3 parts (A, B and C) and will evalua...
Show More Location
Rigshospitalet, Onkologisk Klinik
Learn More & Join Trial